Live feed16:05:00·158dPRReleasevia QuantisnowEledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago MedicineByQuantisnow·Wall Street's wire, on your screen.ELDN· Eledon Pharmaceuticals Inc.Health Care
